An innovative new field of research holds the promise for pediatric cardiologists and heart surgeons to predict the future structural integrity of a child’s heart valves so they can perform the best possible surgery today. At the University of Oklahoma, a pediatric heart surgeon and cardiologist are collaborating with a biomedical engineer in a type of research that few in the nation are doing.
 

University of Oklahoma College of Medicine researcher Paul L. DeAngelis, Ph.D., has been awarded the President’s Innovator Award by the Society for Glycobiology.

New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia, a debilitating muscle-wasting condition that almost always occurs in people diagnosed with pancreatic cancer.

Second-year University of Oklahoma pediatric resident Dr. Caroline Thompson has a professional and personal connection to cystic fibrosis patient care for children. A childhood friend had the disease and made a lasting impression on Thompson. Now, Thompson has received the Cystic Fibrosis Foundation’s Medical Resident Research Award for a pilot study evaluating pharmacogenomic-directed therapy for pediatric patients at the Oklahoma Cystic Fibrosis Center Tulsa.

The University of Oklahoma’s Master of Health Administration and Policy — the only MHA degree program offered in Oklahoma — has been reaccredited for a seven-year term by the Commission on Accreditation of Healthcare Management Education.